LENSAR, Inc.
General ticker "LNSR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $141.2M (TTM average)
LENSAR, Inc. does not follow the US Stock Market performance with the rate: -26.2%.
Estimated limits based on current volatility of 1.1%: low 11.98$, high 12.25$
Factors to consider:
- Earnings expected soon, date: 2026-03-10 bmo
- Total employees count: 140 (+7.7%) as of 2024
- US accounted for 62.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Geopolitical risks, Liquidity and credit risks, Cybersecurity threats, Supply chain disruptions
- Current price 34.9% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.96$, 11.34$]
- 2025-12-31 to 2026-12-31 estimated range: [3.78$, 9.05$]
Financial Metrics affecting the LNSR estimates:
- Negative: with PPE of -3.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.40 <= 0.01
- Positive: -4.43 < Investing cash flow per share per price, % of -2.28
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of -1.37 <= -0.16
- Negative: Shareholder equity ratio, % of 7.33 <= 19.40
Short-term LNSR quotes
Long-term LNSR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $35.36MM | $42.16MM | $53.49MM |
| Operating Expenses | $55.53MM | $54.39MM | $64.16MM |
| Operating Income | $-20.18MM | $-12.23MM | $-10.66MM |
| Non-Operating Income | $0.26MM | $-2.15MM | $-20.74MM |
| R&D Expense | $11.81MM | $6.14MM | $5.33MM |
| Income(Loss) | $-19.91MM | $-14.38MM | $-31.40MM |
| Profit(Loss)* | $-19.91MM | $-14.38MM | $-31.40MM |
| Stockholders Equity | $41.98MM | $33.43MM | $4.86MM |
| Inventory | $11.74MM | $15.69MM | $11.43MM |
| Assets | $55.84MM | $69.58MM | $66.30MM |
| Operating Cash Flow | $-14.86MM | $-9.66MM | $-2.27MM |
| Capital expenditure | $0.12MM | $0.24MM | $0.16MM |
| Investing Cash Flow | $-0.12MM | $-4.16MM | $-2.16MM |
| Financing Cash Flow | $-1.99MM | $19.76MM | $0.08MM |
| Earnings Per Share** | $-1.96 | $-1.31 | $-2.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.